Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release Jan 22 2025
Business
Jan 22 2025
4 min read

Press Release Jan 22 2025

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 22, 2025, titled "Zydus announces USFDA Orphan Drug Designation to Usnoflast for the treatment of Amyotrophic Lateral Sclerosis (ALS)".

View Attachment